EUVIMEDEUVIMED entdecken
Crossref

P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma

Laurie Clauzon, Kimiya SHAMS, Roberta DRAGO, Martina CUCCHIARA, Dionne Blangé, Maarten Bijlsma, Simone D I FRANCO, Giorgio STASSI

Diseases of the Esophagus · 22.08.2026 · 39 (Supplement_1)

DOI: 10.1093/dote/doag077.253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 22.08.2026. Verfasst von Laurie Clauzon und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topic Esophageal Cancer: Molecular Biology/Pathology Background Resistance to perioperative FLOT chemotherapy remains a major determinant of poor outcome in esophageal adenocarcinoma. Epithelial–mesenchymal plasticity (EMP) enables dynamic cell state transitions that may promote adaptive chemoresistance, yet its functional contribution to chemoresistance in esophageal adenocarcinoma remains insufficiently characterized.

Methods

Esophageal adenocarcinoma cell models were engineered to stably express a dual-fluorescent reporter system driven by E-cadherin and vimentin promoters, allowing real-time visualization of epithelial, mesenchymal, and hybrid epithelial/mesenchymal (E/M) states. Fluorescence-Activated Cell Sorting was used to isolate phenotypically distinct subpopulations. Sensitivity to FLOT chemotherapy was assessed using cell viability and clonogenic survival. Dynamic state transitions were evaluated following chemotherapy exposure. RNA sequencing on sorted populations will enable the identification of transcriptional programs associated with chemoresistance and EMP.

Results

Distinct epithelial–mesenchymal subpopulations were identified across several cellular models, with marked heterogeneity. One model, FLO1, exhibited all three phenotypic states, including a hybrid E/M population indicative of high plasticity. FLOT chemotherapy exposure induced significant phenotypic shifts toward hybrid states, accompanied by increased survival and persistence of this cell subset. These findings suggest a dynamic, reversible model of chemoresistance driven by EMP rather than fixed cell identity.

Conclusion

Epithelial–mesenchymal plasticity promotes adaptive resistance to FLOT chemotherapy in esophageal adenocarcinoma by enabling dynamic transitions toward therapy-tolerant states. Defining molecular programs underlying these transitions may support the development of treatment strategies that limit resistance and improve patient response to perioperative chemotherapy.

Zitieren

APA

Clauzon, L., SHAMS, K., DRAGO, R., CUCCHIARA, M., Blangé, D., Bijlsma, M., FRANCO, S. D. I., & STASSI, G. (2026). P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma. Diseases of the Esophagus, 39(Supplement_1). https://doi.org/10.1093/dote/doag077.253

Vancouver

Clauzon L, SHAMS K, DRAGO R, CUCCHIARA M, Blangé D, Bijlsma M, et al. P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma. Diseases of the Esophagus. 2026;39(Supplement_1). doi:10.1093/dote/doag077.253

BibTeX
@article{Clauzon2026,
  author = {Clauzon, Laurie and SHAMS, Kimiya and DRAGO, Roberta and CUCCHIARA, Martina and Blangé, Dionne and Bijlsma, Maarten and FRANCO, Simone D I and STASSI, Giorgio},
  title = {P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma},
  journal = {Diseases of the Esophagus},
  year = {2026},
  volume = {39},
  number = {Supplement_1},
  doi = {10.1093/dote/doag077.253}
}
Kostenlos starten →